New Zealand drugs regulator approves use of MDMA to treat severe PTSD

The Guardian 5 h Australia

New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve th

Aggregated from the leading newsrooms of the country. Every story links to its original source.